Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sally Seymour"'
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice.
The U.S. Food and Drug Administration (FDA) became aware of postmarketing reports of neuropsychiatric adverse events with Singulair (montelukast) use in 2007. Over the years, the FDA has conducted reviews of the clinical trial safety data, focused an
Autor:
R. Busch, Stacy Chin, C. Sahajwalla, Yupeng Ren, K. Quinto, Katherine E. Freitas, Marie C. Bradley, Rongmei Zhang, Efe Eworuke, Elnara Fazio-Eynullayeva, Catherine A. Panozzo, Sally Seymour, Jianmeng Chen, David Martin, Y. Li, Sandra DeLuccia, Judith C. Maro
Publikováno v:
A48. ENVIRONMENTAL ASTHMA.
Autor:
C. Sahajwalla, David Martin, Yupeng Ren, Katherine E. Freitas, Sally Seymour, Judith C. Maro, Jianmeng Chen, Y. Li, Stacy Chin, R. Busch, Marie C. Bradley, Sandra DeLuccia, V. Huser, Efe Eworuke, Elnara Fazio-Eynullayeva, Catherine A. Panozzo, K. Quinto
Publikováno v:
D57. POPULATION BASED STUDIES ON COPD.
Autor:
Shalini Wickramaratne Senarath Yapa, Jill K. Logan, Lisa Harinstein, Monica A. Muñoz, Rosemarie Neuner, Bhawana Saluja, Chandrahas G. Sahajwalla, Sally Seymour
Publikováno v:
PharmacotherapyReferences. 40(2)
BACKGROUND There is a known drug interaction (DI) between xanthine oxidase (XO) inhibitors and the thiopurine immunosuppressants, azathioprine (AZA) and mercaptopurine (6-MP). Xanthine oxidase inhibition increases concentrations of AZA and 6-MP activ
Autor:
Esther H. Zhou, Sally Seymour, Solomon Iyasu, Elizabeth M. Kang, Margie R. Goulding, Jacqueline M. Major
Publikováno v:
Journal of Asthma and Allergy
Esther H Zhou,1 Sally Seymour,2 Margie R Goulding,1 Elizabeth M Kang,1 Jacqueline M Major,1 Solomon Iyasu1 1Division of Epidemiology, Office of Surveillance and Epidemiology, 2Office of New Drugs, Center for Drug Evaluation and Research, US Food and
Autor:
Eugenio Andraca-Carrera, Nikolay P. Nikolov, Rosemarie Neuner, Sally Seymour, Kusum Mistry, Ya‐Hui Hsueh
Publikováno v:
Arthritis & Rheumatology. 72:877-878
Publikováno v:
New England Journal of Medicine. 378:2461-2463
Inhaled Corticosteroids and LABAs In December, the FDA removed the boxed warning on combination products containing an inhaled corticosteroid and a long-acting beta-agonist. The decision was based on results from recently completed large safety trial
Autor:
Dipak Pisal, Sally Seymour, Jianmeng Chen, Anshu Marathe, Yaning Wang, Yupeng Ren, Ping Ji, Liang Li, Lei He, Yunzhao Ren, Shalini Wickramaratne Senarath Yapa, Rachel Glaser, Nikolay P. Nikolov, Chandrahas G. Sahajwalla
Publikováno v:
Journal of pharmaceutical sciences. 108(7)
Determination of appropriate pharmacokinetic end point to bridge different dosing regimens is often a challenge when developing a new route of administration. Trough concentrations (Ctrough) are often considered the most relevant PK end point to pred
Autor:
Julia Pinto, Craig M. Bertha, Ramesh Sood, Sally Seymour, Giuseppe Randazzo, Jennifer Lan, Miya Paterniti
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 7:2948
Autor:
Jacqueline M. Major, Jie Li, Esther H. Zhou, Yulan Ding, Sally Seymour, Thomas Ly, Simone P. Pinheiro
Publikováno v:
Journal of managed carespecialty pharmacy. 24(7)
The FDA issued 2 main drug safety communications (DSCs) on the cardiovascular safety of tiotropium in March 2008 (warning of a potential increased stroke risk) and January 2010 (informing of an absence of a significant increased stroke risk or cardio